Literature DB >> 17465817

Adult neurogenesis and neurodegenerative disease.

Barbara Steiner1, Susanne Wolf, Gerd Kempermann.   

Abstract

Advances in stem cell biology of the adult brain and the discovery of adult neurogenesis have raised the hope that neurodegenerative disorders might ultimately become amenable to causal therapy. Stem cells contribute to cellular plasticity during the lifespan, and in some sense, brain development never ends. However, neurodegeneration is not just a lack of neuroregeneration, and cell genesis in the adult brain does not apparently lead to successful endogenous responses to neurodegeneration. The brain heals poorly; nevertheless, the onset, severity and progression of neurodegenerative disorders show large variation and can often be influenced by cognitive training and physical activity. Rather than providing endogenous repair, cellular plasticity, including adult neurogenesis might thus contribute to the 'cognitive reserve' that determines how well an organism can compensate for neurodegeneration. From this perspective, neurodegenerative disorders, such as Alzheimer's, Parkinson's, Lewy body and Huntington's diseases, might share a relevant biological principle that even links them to psychiatric disorders, like depression, which are not considered 'neurodegenerative' in a classical sense. However, the integration of neuroregenerative phenomena and most notably adult neurogenesis into the concepts of neurodegeneration is not without problems and remains speculative at present. Adult neurogenesis might be part of the physiological regenerative response and might thereby alter or alleviate symptoms, but it might also become impaired by the disease mechanism and thereby contribute to the symptoms of neurodegeneration. In any case, the extent to which effects on the level of cellular plasticity, be it degenerative or regenerative, are relevant functionally remains to be determined. The present review gives an overview of what is known about cell genesis and adult neurogenesis in neurodegenerative disorders and discusses how cellular plasticity might be part of concepts that integrate aspects of development and cellular plasticity into neurodegeneration.

Entities:  

Mesh:

Year:  2006        PMID: 17465817     DOI: 10.2217/17460751.1.1.15

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  26 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 2.  Activity Dependency and Aging in the Regulation of Adult Neurogenesis.

Authors:  Gerd Kempermann
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

3.  NeuroD1 induces terminal neuronal differentiation in olfactory neurogenesis.

Authors:  Camille Boutin; Olaf Hardt; Antoine de Chevigny; Nathalie Coré; Sandra Goebbels; Ralph Seidenfaden; Andreas Bosio; Harold Cremer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

Review 4.  Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migration.

Authors:  Christopher C Young; Keith J Brooks; Alastair M Buchan; Francis G Szele
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

5.  Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.

Authors:  Jose A Morales-Garcia; Rosario Luna-Medina; Sandra Alonso-Gil; Marina Sanz-Sancristobal; Valle Palomo; Carmen Gil; Angel Santos; Ana Martinez; Ana Perez-Castillo
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

Review 6.  Function and Dysfunction of Adult Hippocampal Neurogenesis in Regeneration and Disease.

Authors:  Lei Peng; Michael A Bonaguidi
Journal:  Am J Pathol       Date:  2017-10-10       Impact factor: 4.307

7.  Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway.

Authors:  Shashi Kant Tiwari; Brashket Seth; Swati Agarwal; Anuradha Yadav; Madhumita Karmakar; Shailendra Kumar Gupta; Vinay Choubey; Abhay Sharma; Rajnish Kumar Chaturvedi
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

Review 8.  Stem-cell-associated structural and functional plasticity in the aging hippocampus.

Authors:  Sebastian Jessberger; Fred H Gage
Journal:  Psychol Aging       Date:  2008-12

9.  cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Authors:  Philipp Spitzer; Hans Wolfgang Klafki; Kaj Blennow; Luc Buée; Hermann Esselmann; Sanna-Kaisa Herruka; Connie Jimenez; Peter Klivenyi; Piotr Lewczuk; Juan Manuel Maler; Katrin Markus; Helmut E Meyer; Chris Morris; Thorsten Müller; Markus Otto; Lucilla Parnetti; Hilkka Soininen; Susanna Schraen; Charlotte Teunissen; Laszlo Vecsei; Henrik Zetterberg; Jens Wiltfang
Journal:  Int J Alzheimers Dis       Date:  2010-09-19

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.